Surgical treatment of perforated gastric tumors

Table 1 Clinical characteristics of patients with perforated gastric cancer according to initial surgical approach - primary perforation repair and one-stage gastrectomy groups

Variables	Primary perforation repair, n = 26	One-stage gastrectomy, n = 10	P value
Sex, n (%)			0.722
Female	11 (42.3)	5 (50)
Male	15 (57.7)	5 (50)
Age (years)	61 ± 13.4	66.5 ± 11.3	0.263
Body mass index (kg/m²)	21.1 ± 4.6	23.5 ± 3.0	0.145
Hemoglobin (g/dL)	10.5 ± 2.3	10.2 ± 2.4	0.736
< 11, n (%)	17 (65.4)	7 (70)	1.0
Albumin (g/dL), n (%)	3.0 (0.9)	3.2 (0.7)	0.492
< 3.5	16 (61.5)	6 (60)	1.000
Neutrophil-to-lymphocyte ratio	1.92 ± 1.15	2.56 ± 1.16	0.145
Charlson-Deyo comorbidity index, n (%)			0.688
0	19 (73.1)	6 (60)
≥ 1	7 (26.9)	4 (40)
American Society of Anesthesiologists, n (%)			0.260
I/II	9 (34.6)	6 (60)
III/IV	17 (65.4)	4 (40)
Tumor location, n (%)			0.709
Distal third	9 (34.6)	5 (50)
Middle third	4 (15.4)	1 (10)
Proximal third	9 (34.6)	4 (40)
Linite plastica	4 (15.4)	0 (0)
Lauren type, n (%)			0.024
Intestinal	12 (46.2)	9 (90)
Diffuse/mixed	14 (53.8)	1 (10)
Histological tumor grade, n (%)			0.014
Well/moderately differentiated	4 (15.4)	6 (60)
Poorly differentiated	22 (84.6)	4 (40)